Year of Expanding into Circulating Biomarkers

Shidong Jia; Winston Patrick Kuo

doi:10.33393/jcb.2015.2051

Authors

Shidong Jia Genentech Inc., South San Francisco, USA
Winston Patrick Kuo IES Diagnostics, Inc., Cambridge, USA

DOI:

https://doi.org/10.33393/jcb.2015.2051

Keywords:

Extracellular vesicles, exosomes, microvesicles, circulating tumour cells, cell-free circulating DNA, editorial

Abstract

This editorial article summarizes the achievements and current challenges for the Journal of Circulating Biomarkers (JCB) regarding a more strategic approach to branding and attracting a high quality variety of articles. More emphasis is placed on fostering engagement with academic and industry sources operating at the cutting-edge of translational technologies applied to the field of circulating biomarkers (interface between extracellular vesicles including exosomes and microvesicles, circulating tumour cells, cell-free circulating DNA and circulating protein markers) and with those in the investment arena seeking and providing private funding for this area of research.